produce analgesia by acting upon the body’s opioid receptors. . 118. Guidance on developing non-addictive medical products to treat pain or addiction Not later than 1 year after the date of enactment of this Act, the Secretary of Health and Human Services shall issue draft guidance under section 3001(b) of the SUPPORT for Patients and Communities Act ( 21 U.S.C. 355 note) to address non-addictive analgesics for chronic pain, including the information required to be included in guidance documents under paragraphs (1) through (4) of such section 3001(b). 119. National Chronic Pain Information System Part P of title III of the Public Health Service Act ( 42 U.S.C. 280g et seq. ) is amended by adding at the end the following: 399V–8. Chronic pain research (a) In general The Secretary, in consultation with the Director of the Centers for Disease Control and Prevention, the Director of the National Institutes of Health, and other agencies as the Secretary determines appropriate, shall— (1) utilize available Federal research data to clarify the incidence and prevalence of chronic pain from any source, including injuries, operations, and diseases and conditions